Filinvest Development Coproration vs Jiangsu Hengrui Pharma Co: Fair Value & Quality
Both stocks run through our valuation models. Here is how Filinvest Development Coproration (FDC) and Jiangsu Hengrui Pharma Co (1276) compare, as of Aug 21, 2026.
Head-to-head numbers
Green value = the better side for that row (for valuation multiples: lower = cheaper).
Even match: 4 to 4 metric wins.
Dash = not meaningfully computable, for example with negative equity.
Quality in detail
The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.
What the models say
The median fair value (base case) per model family, each in the currency of its trading venue. Green = above the current price, red = below.
Filinvest Development Coproration
2 of 6 models see the stock below the current price.
Jiangsu Hengrui Pharma Co
22 of 24 models see the stock below the current price.
Scenario ranges
From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.
Compare two other stocks
Tap a field and type again, ticker or company name.
Ranked within their sector
Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.
Filinvest Development Coproration · Financials
Jiangsu Hengrui Pharma Co · Healthcare
Bottom line
As of Aug 21, 2026, Fair Value Calculator sees Filinvest Development Coproration as the more attractively valued of the two: Filinvest Development Coproration trades at PHP 3.87 versus a fair value of PHP 8.54 (+121%), while Jiangsu Hengrui Pharma Co trades at HK$49.66 versus HK$33.59 (-32%).
Jiangsu Hengrui Pharma Co has the higher quality score (67/100).
See the full analysis →More comparisons
Popular match-ups from the same sectors, all with fair value and quality score.
Related to Filinvest Development Coproration
Alphabet Inc Class C vs Verizon CommunicationsAlphabet Inc Class C vs At&tAlphabet Inc Class C vs NetEaseAmazon.com vs PDD HoldingsRelated to Jiangsu Hengrui Pharma Co
Amazon.com vs Sony GroupMeta Platforms vs Verizon CommunicationsMeta Platforms vs At&tMeta Platforms vs NetEaseSee the undervalued quality stocks every month
Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.
A model-based valuation snapshot from 21 models. Values change with price and fundamentals; the date shown above applies.